Drug profile · INN
cefepime hydrochloride
CEFEPIME HYDROCHLORIDE
cefepime hydrochloride (CEFEPIME HYDROCHLORIDE) is a bacterial penicillin-binding protein inhibitor. Route of administration: injection. Current US regulatory status: approved.
Drug details — cefepime hydrochloride
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
cefepime hydrochloride (CEFEPIME HYDROCHLORIDE) is a bacterial penicillin-binding protein inhibitor. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
Bacterial penicillin-binding protein inhibitor
Primary target: Bacterial penicillin-binding protein
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is cefepime hydrochloride?
cefepime hydrochloride (CEFEPIME HYDROCHLORIDE) is a bacterial penicillin-binding protein inhibitor. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for cefepime hydrochloride?
CEFEPIME HYDROCHLORIDE is a marketed brand name for cefepime hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of cefepime hydrochloride?
cefepime hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.